CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (USD $)	Jun. 30, 2013	Dec. 31, 2012
Current Assets:
Cash and cash equivalents	$ 116,887	$ 1,892
Accounts receivable	31,653	14,133
Inventory	11,184
Deferred financing costs	21,787	2,203
Prepaid assets and other	3,050
Total current assets	184,561	18,228
Current Liabilities:
Accounts payable and accrued expenses	146,987	99,130
Deferred compensation	3,000	40,880
Convertible debt, net of discounts of $50,150 (2013) and $19,648 (2012)	42,350	35,852
Convertible note payable (net of discount of $17,111)	210,389
Derivative liabilities	122,792	38,590
Litigation contingency		46,449
Total current liabilities	525,518	260,901
Commitments and Contingencies
STOCKHOLDERS DEFICIENCY
Series B convertible preferred stock, $0.01 par value; 1,000,000 shares authorized, 1,000,000 (2013) and 800,000 (2012) shares issued and outstanding	10,000	8,000
Common stock, $.01 par value; 500,000,000 shares authorized; 445,456,717 (2013) shares and 466,632,164 (2012) shares issued and outstanding	4,454,569	4,666,324
Additional paid in capital	3,714,104	202,372
Deferred stock compensation	(22,207)	(222,083)
Accumulated deficit	(8,497,423)	(4,897,286)
Total stockholders' deficiency	(340,957)	(242,673)
Total liabilities and stockholders deficiency	$ 184,561	$ 18,228